We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Combined Automated Blood Tests Estimate Prostate Cancer Probability

By LabMedica International staff writers
Posted on 19 Apr 2010
Three automated blood tests combined into one index estimates a man's probability of having prostate cancer found on biopsy.

A new prostate disease marker, p2prostate-specific antigen (p2PSA), and the Prostate Health Index (phi), significantly improve the specificity of prostate cancer biomarker assessment. More...


Serum Beckman Coulter (Nyon, Switzerland) phi is a multivariate index incorporating prostate-specific antigen (PSA), free PSA, and proPSA concentrations into a single result. This enables medical professionals to estimate the probability of cancer in men aged 50 and older with total PSA in the 2.0-10.0 ng/mL range and a nonsuspicious digital rectal examination (DRE).

proPSA is a novel serum marker strongly associated with prostate cancer and delivers added specificity to PSA. As a result, phi contributes to reduce significantly the number of negative biopsies resulting from suspicious PSA or free PSA results.

Beckman Coulter phi is a composite score of Access Hybritech PSA, free PSA and the new p2PSA assay, which measures the isoform proPSA.

A new website introduced by Beckman Coulter, was designed to encourage dialogue between patients, physicians, and laboratory professionals. It provides guidance and education to all parties in order to foster confident prostate biopsy decision-making. The website (please see related links below) provides links to credible medical resources, the latest unbiased scientific studies, and details the benefits of the latest blood test, which can noninvasively identify patients who are most likely to have a negative prostate biopsy.

Related Links:

Beckman Coulter

Prostate Health Index



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Platelet Function Analyzer
PL-12
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.